ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
- 1 January 1989
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 333 (8630) , 117-120
- https://doi.org/10.1016/s0140-6736(89)91141-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The Christie hospital adjuvant tamoxifen trial – status at 10 yearsBritish Journal of Cancer, 1988
- Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancerBritish Journal of Cancer, 1988
- Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancerBritish Journal of Cancer, 1988
- The Stockholm trial on adjuvant tamoxifen in early breast cancerBreast Cancer Research and Treatment, 1987
- Menopausal oestrogens and breast cancer risk: An expanded case-control studyBritish Journal of Cancer, 1986
- Cancer of the liver and the use of oral contraceptives.BMJ, 1986
- Tamoxifen and Combination Chemotherapy as Adjuvant Treatment in Postmenopausal Women with Breast CancerPublished by Springer Nature ,1984
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Increased Risk of Endometrial Carcinoma among Users of Conjugated EstrogensNew England Journal of Medicine, 1975
- Association of Exogenous Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1975